This edition corrects a missing featured article and a few links to external articles and CE submissions. |
|
September/October 2021 Newsletter
Special Edition
|
|
In This Issue:
- President's Message
- Board of Director's Update
- Public Policy Update
- R & E Foundation Update
- Pharmacist Continuing Education Articles
-
Kids Survive: Evidence Based Management of Pediatric Sepsis
- Aminoglycoside and Vancomycin Dosing in Pregnancy
- Featured Clinical Topic: Minimalist Approach to Combat Polypharmacy: Deprescribing Antihypertensive Medications in the Geriatric Population
- Featured Clinical Topic: ClinicaI Impact of Isolation Among Older Adults due to COVID-19 Pandemic: A Focus on Functional and Psychological Effects and Implications for Pharmacists
- Featured Clinical Topic: Cost Benefit of Pharmacist Led Transitions of Care Programs
- Affiliate Chapter News and Events
- Upcoming Newsletter Info
|
|
By Christina Stafford, PharmD, BCPS; MSHP President; CoxHealth, Springfield |
“Be safe, be smart, be kind.”- Dr. Tedros Adhanom Ghebreyesus, WHO Director General
“Hardships often prepare ordinary people for an extraordinary destiny.”- C.S Lewis
Alas, another Summer is nearly over. I hope all of you were able to safely escape from home, if even for a day trip, to recharge yourselves during these trying times.
MSHP had a very busy Summer! In July, several of our members met with the offices of three of our congressional members to discuss the federal provider status bill and answer their questions. These meetings were informative, and we received positive feedback from the offices. Last month was a fantastic white-bagging webinar presented by Nathan Hanson and Joel Hennenfent that was well attended by our members. Last month also kicked off preparations for the Spring Meeting with KCHP. The Board also approved our strategic plan and we look forward to sharing that with all of you!
As much as I love Summer, I always look forward to Fall. The changing leaves, bonfires, football and knowing I will get to spend time with family. This Fall will look a little different for many of us as sadly Midyear has been moved to a virtual platform once again. We are still planning a virtual luncheon for members to attend to celebrate all that we have done this year. I hope many of you will be able to attend.
I am looking forward to all the fantastic education opportunities that will be offered by the Education and R&E Committees and the New Practitioner Workgroup. Stay tuned!!
I wish everyone a very safe and Happy Fall!
|
|
Board of Director's Update |
|
Board Update
By: Nathan Hanson, PharmD, MS, BCPS
July
- Official welcome to new Board of Directors! Thank you to members finishing their terms on the board!
- Discussed MSHP’s management company performance survey results. Jim is finalizing the proposed contract.
- Proposed bylaws change to make technician liaison a voting member of the BOD. Email vote will be sent to all MSHP members.
- Work is ongoing to create a policy that outlines how MSHP will make position statements.
- The board discussed various strategies for impacting vaccine hesitancy in Missouri including putting together FAQ sheets and potential drug company resources.
August
- Cassie Heffern was recognized for her recent presentation at the ASHP Ambulatory Care Pearls
- The Public Policy committee reported 3 successful Virtual Meetings with US Congressional staffers, hosted by ASHP staff.
- We can celebrate that the St. Louis County PDMP has finally appeared on the federal PDMP, because Missouri passed the PDMP bill! This is the first step towards a truly comprehensive PDMP.
- Spring Meeting planning committee and Jim Andrews are considering our options (virtual vs in-person). Conversations are ongoing with KCHP leadership.
- The Board started to review the 2021-2022 Strategic Plan
- ASHP Invitation for Comment: Review of ACPE 2025 Standards
|
|
Annie Stella, PharmD, BCPS; Centerpoint Medical Center, Independence, MO |
|
HIV Post-Exposure Prophylaxis – the expanding role of the Pharmacist
Missouri’s legislature is just the third state legislature in the United States to make emergency HIV post-exposure prophylaxis (PEP) available without a prescription at facilities or pharmacies that have a protocol in place with a licensed physician. This proposed rule is currently being drafted by the Missouri Board of Pharmacy.
The proposed language can be found in the meeting minutes from the Aug 18 th board meeting found here
|
|
A protocol must be established with a licensed physician or hospital medical staff committee. This opportunity to expand our role in the care for our patients requires that pharmacists have the proper training. In the drafted language by the Board of Pharmacy this means a Missouri licensed pharmacist has completed a training course or certification program that includes training in CDC guidelines for HIV post-exposure prophylaxis. The training course or certification program must be accredited by the U.S. Centers for Disease Control and Prevention, the Accreditation Council for Pharmacy Education (ACPE) or the Accreditation Council for Continuing Medical Education. An alternative is that the program was provided by an ACPE or regionally accredited pharmacy or medical school/college.
For a full list of the proposed provisions required in an HIV PEP protocol please see the draft from the latest Board of Pharmacy meeting linked above.
MSHP would love to hear your questions, concerns or comments regarding this ruling and how MSHP can help you at annemstella@outlook.com.
|
|
Research & Education Foundation Update: |
|
The MSHP R&E Foundation has been hard at work creating new educational offerings for the upcoming year.
First, we are sponsoring a Ground Rounds Series for residency programs throughout the state. In the Grand Round Series, Missouri-based pharmacy residents have the opportunity to present a 1-hour CE presentation to MSHP members and local pharmacists.
To register for this series as a presenter please do so here:
|
|
To register as a moderator, please do so here: |
|
All attending preceptors will be asked to evaluate the resident Grand Round presenters.
Interest in this event has been so strong that our original plan to have one session per month has already been increased to two session per month.
Details about dates, times, and links for attendance will be distributed soon.
Secondly, we are planning a quarterly Preceptor Development Series. This series will be a combination of didactic lecture, group presentations, and panel discussion on various topics. Our first session will be focused on Communication & Active Listening, as is being planned for October 2021. Additional details for this event and subsequent sessions will be distributed soon.
A huge thank you to Megan Musselman and Sara Lauterwasser for coordinating the Ground Rounds Series and Alex Oschman for coordinating the Preceptor Development Series.
Lastly, with the recent announcement regarding the ASHP Midyear Clinical Meeting reverting to a virtual only meeting, we are working towards a virtual reception option for the week of Midyear. Our annual Midyear reception not only offers vitally important networking opportunities but is also a time to recognize successes through the year for MSHP, MSHP R&E, and our state Pharmacy Schools.
Respectfully submitted,
|
|
Tony Huke, Pharm.D., BCPS
MSHP R&E Executive Director
|
|
Kids Survive: Evidence Based Management of Pediatric Sepsis
Author: Victoria H. Anderson, PharmD; PGY-1 Pharmacy Resident (2020-2021)
Mentor: Jordan E. Anderson, PharmD, BCPS, BCCPS; Pharmacy Clinical Coordinator/PGY-1 Residency Program Director
University of Missouri Women’s and Children’s Hospital – Columbia, MO
|
Program Number: 2021-09-04
Approval Dates: October 1, 2021 - April 1, 2022
Approved Contact Hours: 1 hour (1) CE per session
Learning Objectives
- Distinguish features of SIRS, sepsis, severe sepsis, and septic shock.
- Describe initial management of pediatric sepsis patients.
- Differentiate medications with and without a routine role in pediatric sepsis management.
|
|
Program Number: 2021-09-05
Approval Dates: October 1. 2021-April 1, 2022
Approved Contact Hours: One Half Hour(s) (0.5) CE(s) per session
Aminoglycoside and Vancomycin Dosing in Pregnancy
Author: Jamie Prashek, PharmD; PGY-1 Pharmacy Resident (2020-2021)
Mentor: Mentor: Jordan E. Anderson, PharmD, BCPS, BCCPS; Pharmacy Clinical Coordinator/PGY-1 Residency Program Director
University of Missouri Women’s and Children’s Hospital – Columbia, MO
Learning Objectives:
1. Recognize appropriate aminoglycoside agent of use in pregnant women
2. Discuss safe and efficacious doses of aminoglycosides and vancomycin in pregnant women
|
|
Featured Clinical Topic: Minimalist Approach to Combat Polypharmacy: Deprescribing Antihypertensive Medications in the Geriatric Population
|
|
By: Sreemathi Palanisamy, PharmD Candidate 2022, Thara Kottoor, PharmD Candidate 2022, St. Louis College of Pharmacy at University of Health Sciences and Pharmacy in St. Louis
Mentor: Haley N. Johnson, PharmD, BCPS; Assistant Professor, Department of Pharmacy Practice, St. Louis College of Pharmacy at University of Health Sciences and Pharmacy in St. Louis
The general population is aging as 10,000, “Baby Boomers,” are turning 65 years old each day in the United States. It is predicted that older adults will comprise 20% of the population by the year 2030.1 With the increasing geriatric population, the number of patients with age-related chronic conditions is rising, as well. Elderly patients are prescribed multiple medications to control their chronic illnesses, which increases the risk for adverse events, poor adherence, and direct and indirect healthcare costs.
|
|
Featured Clinical Topic:
ClinicaI Impact of Isolation Among Older Adults due to COVID-19 Pandemic:
A Focus on Functional and Psychological Effects and Implications for Pharmacists
|
|
By: Caroline Minn and Maryam Azam, PharmD Candidates 2022; St. Louis College of Pharmacy at University of Health Sciences and Pharmacy in St. Louis
Mentor: Hedva Levy, PharmD, BCPS, BCGP; St. Louis College of Pharmacy at University of Health Sciences and Pharmacy in St. Louis
|
|
The COVID-19 pandemic has been a source of unexpected challenges for the geriatric population. This older age group has been the most vulnerable because of the higher prevalence of chronic conditions such as heart disease, diabetes, and arthritis, combined with a weaker immune system. The pandemic also has had a great impact on the older population’s mental health and physical health as well. The pandemic is increasing the number of older adults who are socially isolated as many countries have issued lockdowns in the community and nursing home settings and prevented visitors at hospitals.
Social isolation is defined as the objective state of having few social relationships or infrequent social contact with others while loneliness is a subjective feeling of being isolated.¹ Because social isolation and loneliness are major risk factors that have been linked with poor physical and psychological function in older adults, it is important to address these issues and promote solutions to help mitigate the negative consequences of loneliness and isolation.¹ The purpose of this article is to provide an overview of the clinical impact of isolation on older adults during COVID-19, pandemic-related barriers to medication adherence, and pharmacists’ considerations to mitigate these challenges.
|
|
Featured Clinical Topic:
Cost Benefit of Pharmacist Led Transitions of Care Programs
|
|
By: Colton Frazer, MBA, PharmD Candidate 2022;
Mentor: Dr. Paul Juang, PharmD, BCCCP, BCPS, FAHP, FCCM
|
|
The National Transitions of Care Coalition estimated that the United States wastes around 30 to 50 billion dollars in unnecessary medical expenditures to fix transitional care errors each year. Approximately 60% of which are medication related errors. With this in mind, the argument can be made that more emphasis should be placed on pharmacist-led transitions of care (TOC) programs to ensure patients are properly educated on their new medications. Furthermore, this would be a great area for pharmacists to make a positive impact, while expanding our scope of practice. The continuing trend of pharmacists expanding their scope of practice is becoming more and more relevant each year. For example, H.R. 2759/S. 136 is a bill currently in discussion that would add pharmacists to the providers list eligible for Medicare part B service reimbursement. While provider status may continue to elude our profession, pharmacists are the ideal choice to lead TOC programs-- and can successfully implement these programs now. Furthermore, these programs would likely pay for themselves by reducing emergency medical costs paid by health systems. |
|
Featured Clinical Topic:
The Pharmacist’s Role: Transition of Care for Heart Failure Patients
|
|
By: Sarah Schriewer and Megan Smith, PharmD Candidates 2023; St. Louis College of Pharmacy at University of Health Sciences and Pharmacy in St. Louis
Mentor: Roxane Took, PharmD, BCACP; Assistant Professor, Department of Pharmacy Practice, St. Louis College of Pharmacy at University of Health Sciences and Pharmacy in St. Louis; Gateway Apothecary
Background
The increased prevalence of heart failure readmissions proves costly for both hospital health systems and patients. More than 20% of hospitalized heart failure patients will return for readmission within a 30-day period.1 Within the last ten years, the Centers for Medicare and Medicaid reduced reimbursement to health systems with excessive 30-day readmission rates in order to curb the climbing occurrence and associated costs of these readmissions.2 This was done to remove incentivizing procedures that may lessen the quality of patient care.3 Many hospitals have established transition of care (TOC) teams composed of various healthcare personnel following this reimbursement limitation.4 The inclusion of the pharmacy profession on the TOC team remains essential, as confirmed by numerous studies that examined the purpose, involvement, and outcomes related to pharmacy specifically. Through performance and accountability measures, the Joint Commission closely examines the efforts of hospitals to improve heart failure patient outcomes.5 Pharmacists play an integral role in improving standards for TOC in heart failure patients.
|
|
Greater Kansas City Society of Health-System Pharmacists (GKCSHP)
President: Kerra Cissne, PharmD, BCPS (kerra.cissne@gmail.com)
______________________________________________________________________
Mid-Missouri Society of Health-System Pharmacists (MMSHP)
President: Alexandria Stringberg, PharmD, BCPS (stringberga@health.missouri.edu)
_______________________________________________________________________
Saint Louis Society of Health-System Pharmacists (STLSHP)
October: 10/21 – Save the date for upcoming dinner program!
November: 11/17 – STLSHP Networking Happy Hour following Resident Seminars, location TBD
President: Yvonne Burnett, Pharm.D., BCIDP (Yvonne.Burnett@uhsp.edu)
_______________________________________________________________________
Southeast Missouri Society of Health-System Pharmacists (SEMSHP)
President: Janice Wesbecher (jbueter@sehealth.org)
|
|
Upcoming Featured Clinical Topics:
- Nov/Dec 2021: Infectious Disease/Vaccines- FULL
- Jan/Feb 2022: Endocrinology/Obesity Management - FULL
- March/April 2022: Psychiatry/Pain/Substance Use Disorder - FULL
- May/Jun 2022: Critical Care/Pulmonary/Emergency Medicine
- July/August 2022: Cardiology/Anticoagulation
- Sept/Oct 2022: Special Populations (Geriatrics, Pediatrics, Women’s/Men’s Health)/Transitions of Care
- Nov/Dec 2022: ID/Vaccines
|
|
Newsletter Submission Deadlines:
- Nov/Dec 2021: Due October 25
- Jan/Feb 2022: Due December 27
- March/April 2022: Due February 28,
- May/Jun 2022: Due April 25
- July/August 2022: Due June 27
- Sept/Oct 2022: Due August 22
- Nov/Dec 2022: Due October 24
|
|
Newsletter Submission Guidelines
- Pharmacists, pharmacy technicians, and pharmacy students in Missouri are eligible to submit content for publication in the MSHP Newsletter. Student submissions need to include pharmacist oversight.
- Submit content to the current Newsletter Committee Chair on or before the established deadlines.
- CE and Featured Clinical Topics must be approved by the Newsletter Committee Chair in advance of article submission, to prevent duplicates. Duplicate articles submitted without advanced approval may not be published.
- Recommended length of submissions for committee, affiliate, college/schools of pharmacy, and student chapter reports is half to one page in length.
- Recommended length of submissions for featured clinical topics is 1 to 2 pages, without references.
- Recommended length of CE articles is individualized, based on the amount of CE provided.
- Recommended length of submission for other categories is 1 to 2 pages.
|
|
MSHP Board of Directors & Committee Chairs |
|
2021-2022 Board Members
President:
President-Elect:
Immediate Past President:
|
|
2021-2022 Committee Chairs
Vendor Relations Board Liaison:
Membership Committee:
Public Policy Committee:
Newsletter Committee:
Education and Programming:
Website & Social Media:
|
|
If you have any questions, comments, or wish to submit an article to for MSHP Newsletter, please contact the Newsletter Committee Chair (Laura Challen) or another Newsletter Committee member.
2021-2022 MSHP Newsletter Committee Members
|
|
Your copy should address 3 key questions: Who am I writing for? (Audience) Why should they care? (Benefit) What do I want them to do here? (Call-to-Action)
Create a great offer by adding words like "free" "personalized" "complimentary" or "customized." A sense of urgency often helps readers take an action, so think about inserting phrases like "for a limited time only" or "only 7 remaining!"
|
|
|
|
|
|
|
